Long-term results after the réparation à l'étage ventriculaire procedure for transposition of the great arteries and double-outlet right ventricle with pulmonary stenosis
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad409 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Margaux Pontailler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiac Surgery, Necker Sick Children Hospital and Université de Paris, Paris, France. Hauptthemen laut MEDLINE: Transposition of Great Vessels, Double Outlet Right Ventricle, Ventricular Outflow Obstruction, Left, Cardiac Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES The purpose of this study is to describe the long-term results of the ‘réparation à l’étage ventriculaire’ (REV) technique for double-outlet right ventricle and transposition of the great arteries (TGA) with pulmonary stenosis (PS). METHODS Between 1980 and 2021, 157 patients underwent a REV procedure (median age and weight: 20.8 months and 7.7 kg). The most frequent anatomical presentation was the association between TGA, ventricular septal defect and PS (n = 116, 73.9%). RESULTS Sixty-seven patients (42.7%) underwent a Rashkind procedure, and 67 patients (42.7%) a prior surgical palliation (including 62 systemic-to-pulmonary artery shunts). Resection of the conal septum and/or ventricular septal defect enlargement was performed in 109 patients (69.4%). Thirteen patients (8.3%) died, including 4 during the first postoperative month and 2 after heart transplant. Overall survival at 40 years was 89.3%. Thirty-seven patients (23.6%) required 68 reinterventions on the right ventricular outflow tract (RVOT), including 49 reoperations, with a median delay of 9 years after the REV (8 months to 27 years). Twenty patients (12.7%) underwent RVOT valvulation (16 surgical and 4 interventional). Freedom from RVOT reintervention and reoperation at 40 years were 60.3% and 62.6%, respectively. Four patients (2.5%) required reoperation for left ventricular outflow tract obstruction, with a median delay of 4.8 years. CONCLUSIONS The REV procedure is a good alternative for TGA and double-outlet right ventricle with PS patients. Only a quarter of the patients required redo surgery on the RVOT. Reoperations for left ventricular outflow tract obstruction are scarce.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiac Surgery, Necker Sick Children Hospital and Université de Paris, Paris, France.
- Department of Pediatric Cardiology, Necker Sick Children Hospital-M3C and Université de Paris, Paris, France.
ORCID-Profile: Margaux Pontailler, Lucile Houyel, Damien Bonnet
Zitieren
APA
Pontailler, M., Moiroux-Sahraoui, A., Bernheim, S., Gaudin, R., Houyel, L., Bonnet, D., Vouhé, P., & Raisky, O. (2023). Long-term results after the réparation à l'étage ventriculaire procedure for transposition of the great arteries and double-outlet right ventricle with pulmonary stenosis. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad409
Vancouver
Pontailler M, Moiroux-Sahraoui A, Bernheim S, Gaudin R, Houyel L, Bonnet D, et al. Long-term results after the réparation à l'étage ventriculaire procedure for transposition of the great arteries and double-outlet right ventricle with pulmonary stenosis. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad409
BibTeX
@article{Pontailler2023,
author = {Pontailler, Margaux and Moiroux-Sahraoui, Alexander and Bernheim, Ségolène and Gaudin, Régis and Houyel, Lucile and Bonnet, Damien and Vouhé, Pascal and Raisky, Olivier},
title = {Long-term results after the réparation à l'étage ventriculaire procedure for transposition of the great arteries and double-outlet right ventricle with pulmonary stenosis},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad409}
}
EUVIMED